Vulvar Adenocarcinoma — Trials

Vulvar Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 33%
Top sponsor: Avacta Life Sciences Ltd
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07454642	AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors(FOCUS-01)	recruiting	Phase 1	174	Avacta Life Sciences LtdINDUSTRY	1	Jun 2, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 2, 2026source: clinicaltrials